A comprehensive view of Liver / Kidney / Bladder Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Gilead completes acquisition of CymaBay Therapeutics for US$4.3B, enhancing its liver disease treatment portfolio with lead product candidate seladelpar for primary biliary cholangitis; CymaBay now a wholly owned subsidiary of Gilead

Medtronic's renal denervation system gains Health Canada license to manage hypertension in patients with resistance to lifestyle changes and medication; the system uses radiofrequency ablation to calm nerves near the kidneys

Roche campaign highlights retinal diseases as major health concern, promotes gender equality in healthcare

GSK Group supports Kidney Health Australia's launch of updated kidney disease management handbook on World Kidney Day, reinforcing company's goal to expand public health education and healthcare services accessibility

Bayer AG focuses on innovation and tackling industry challenges, announces upcoming startups under G4A Acceleration Program, and is addressing chronic kidney disease and health issues related to diabetes.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count